MoneyWorks4Me

A fair growth of 22.50% in the revenue at Rs. 14952.50 millions was reported in the June 2022 quarter as compared to Rs. 12206.00 millions during year-ago period.Profit after tax improved marginally to Rs. 2316.10  millions for the quarter ended June 2022 from Rs. 2220.80 millions of corresponding previous quarter.Operating profit surged to 4211.10 millions from the corresponding previous quarter of 3706.30 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202206 202106 % Var 202206 202106 % Var 202203 202103 % Var
Sales 14952.50 12206.00 22.50 14952.50 12206.00 22.50 47070.40 47687.20 -1.29
Other Income 29.30 75.70 -61.29 29.30 75.70 -61.29 215.50 273.20 -21.12
PBIDT 4211.10 3706.30 13.62 4211.10 3706.30 13.62 13067.50 15371.90 -14.99
Interest 275.00 250.40 9.82 275.00 250.40 9.82 958.60 659.20 45.42
PBDT 3936.10 3455.90 13.90 3936.10 3455.90 13.90 12108.90 14712.70 -17.70
Depreciation 660.00 554.90 18.94 660.00 554.90 18.94 2354.80 1966.40 19.75
PBT 3276.10 2901.00 12.93 3276.10 2901.00 12.93 9754.10 12746.30 -23.48
TAX 960.00 680.20 41.13 960.00 680.20 41.13 2253.20 3185.20 -29.26
Deferred Tax -69.80 174.30 -140.05 -69.80 174.30 -140.05 -61.00 -164.60 -62.94
PAT 2316.10 2220.80 4.29 2316.10 2220.80 4.29 7500.90 9561.10 -21.55
Equity 1074.70 1073.20 0.14 1074.70 1073.20 0.14 1074.70 1073.20 0.14
PBIDTM(%) 28.16 30.36 -7.25 28.16 30.36 -7.25 27.76 32.23 -13.88
Peers
Company Name CMP
Sun Pharma. Inds. 1853.00
Dr. Reddys Labs. 1200.40
Cipla 1404.00
Lupin 2098.00
Zydus Lifesciences 1180.00
View more..